bioAffinity Technologies, Inc. (BIAF)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

2.4000

-0.0200

(-0.83%)

At close: 04:00PM EDT

2.3300

-0.07

(-2.92%)

After hours:

06:40PM EDT

Loading interactive chart...

Business Wire
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
SAN ANTONIO, May 15, 2024--bioAffinity Technology reports record Q1 2024 revenue driven by accelerating sales of lung cancer diagnostic CyPath Lung.
Business Wire
bioAffinity Technologies News Update
SAN ANTONIO, May 02, 2024--bioAffinity reports ramp in sales of CyPath® Lung, expanded sales team, new Patient Coach and upcoming presentation at American Thoracic Society.
Business Wire
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
SAN ANTONIO, April 24, 2024--bioAffinity Technologies is developing diagnostics based on its proprietary platform for use with BAL fluid to detect lung cancer and to detect COPD.